Cosmos Health Inc.

COSM - Financial Snapshot

Healthcare sector | Medical Distribution industry

View on:
Ranks:

Metrics for COSM

Price $0.34
Shares Outstanding 37.35M
All-Time Low $0.07
52-Week Low $0.28

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((922,619 - 46,357,874) / 37,346,025) = -1.2166
Net Current Assets / Share $-0.22
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((38,104,289 - 46,357,874) / 37,346,025) = -0.221
Net Tangible Assets / Share $0.41
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((69,492,758 - 7,960,633 - 46,357,874) / 37,346,025) = 0.41
Shares Outstanding Ave Change (Annual) 225.2%
Shares Δ YoY 48.48%
Avg CA Burn (Annual %) -8.00% (as of 2-20-2026)
Avg CA Burn (Quarterly %) 3.52% (as of 2-20-2026)

Earning Metrics

Max Earning Power / Share $-1.05
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((-4,104,382 / 0.105) / 37,346,025) = -1.0467
Adjusted Earning Power $-1.37
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-5,352,890 / 0.105) / 37,346,025) = -1.3651
Non-Cash Charges to Market Cap 2.93%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Y) 0 (as of 2-20-2026)
Avg EBITDA (5Q) 0 (as of 2-20-2026)
Avg Net Income (5Y) -14.1M (as of 2-20-2026)
Avg Net Income (5Q) -4.1M (as of 2-20-2026)
Data as of: Price 03-20-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Current Dividend Streak No 2-20-2026
Consecutive Years Paid No 2-20-2026
Pays Dividend No 2-20-2026
Last Dividend Date 11-20-17
Income indicators Value Date
EBITDA Positive No 2-20-2026
Net Income Positive No 2-20-2026
Current Dividend Streak No 2-20-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2025-09-30 Quarterly $0.48 15.2M ($15,174,251) 31.9M (31,869,041)
2025-06-30 Quarterly $0.61 18M ($18,006,272) 29.7M (29,717,802)
2025-03-31 Quarterly $0.67 18.1M ($18,149,183) 27.2M (27,198,136)
2024-12-31 Quarterly $0.71 16.8M ($16,776,395) 23.6M (23,602,638)
2024-12-31 Annual $0.71 16.8M ($16,776,395) 23.6M (23,602,638)
2024-09-30 Quarterly $1.17 27.2M ($27,229,839) 23.3M (23,259,526)
2023-12-31 Annual $1.78 28.2M ($28,235,436) 15.9M (15,895,975)
2022-12-31 Annual $3.64 38.6M ($38,577,381) 10.6M (10,589,915)
2021-12-31 Annual $5.67 3.9M ($3,893,696) 686.3K (686,283)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-01-05 37,346,025 +64,301
2025-12-23 37,281,724 +2,361,804
2025-11-18 34,919,920 +3,906,044
2025-09-26 31,013,876 +800,000
2025-09-18 30,213,876 -24
2025-08-25 30,213,900 +173,100
2025-08-19 30,040,800 +799,100

Short Interest Changes

Latest short-interest change: 335,495 shares (1.11% of float) | Days to cover: 0.47

Date Short Interest Delta Δ %
2026-03-12 335,495 shares +216,000 +180.76%
2026-02-27 119,495 shares +13,703 +12.95%
2026-02-11 105,792 shares +52,278 +97.69%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.